Clinical Trial Details
— Status: Not yet recruiting
Administrative data
NCT number |
NCT06403657 |
Other study ID # |
DETECT-B protocol |
Secondary ID |
|
Status |
Not yet recruiting |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
May 2024 |
Est. completion date |
July 2025 |
Study information
Verified date |
May 2024 |
Source |
Vietnam Viral Hepatitis Alliance |
Contact |
Thanh Kim, MD |
Email |
thanhkv[@]pnt.edu.vn |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
The overarching goal of this implementation study is to determine if an enhanced model of
hepatitis B testing and linkage to care could be integrated into a public healthcare
facility. To answer this question, the investigators will
1. evaluate the effectiveness of the implementation program (overall impact or individual
components) in increasing the use of testing services and linkage to hepatitis B care
and treatment,
2. evaluate implementation fidelity, sustainability, and integration of the implementation
study and
3. analyze the costs and cost-effectiveness of the implementation study.
Description:
Chronic hepatitis B (CHB) poses a significant public health challenge, particularly in
low-income countries like Viet Nam. Despite the development of various diagnostic and
treatment tools for hepatitis B, the delivery of these services remains suboptimal.
In response, the investigators seek to assess the feasibility of integrating an enhanced
model for hepatitis B testing and linkage to care within a public healthcare facility. The
study aims to address this issue through several key objectives:
1. Effectiveness Evaluation: The investigators will evaluate the impact of the
implementation program on increasing the utilization of testing services and linkage to
hepatitis B care and treatment. This includes assessing the overall impact as well as
the effectiveness of individual program components.
2. Implementation Fidelity and Sustainability: The investigators aim to evaluate the
fidelity of implementation, examine how well the program is executed, and assess its
potential for sustainability and integration into routine healthcare practices.
3. Cost and Cost-Effectiveness Analysis: The investigators will analyze the costs
associated with the implementation of the program and its cost-effectiveness in
improving hepatitis B testing and linkage to care.
The implementation study is based at Le Van Thinh Hospital in Thu Duc City, Ho Chi Minh City.
This study is guided by the EPIS (Explore - Prepare - Implement - Sustain) conceptual
framework, which informs our research development, implementation, and evaluation strategies.
A mixed-method quasi-experimental type II hybrid effectiveness-implementation design will be
employed. This involves implementing various strategies to enhance hepatitis B testing
sequentially over a 12-month period. Strategies include medical education for primary care
providers, electronic medical record-based reminders for testing, and point-of-care testing
for CHB.
Effectiveness will be assessed using interrupted time series analysis with electronic medical
record data. Sustainability will be gauged through interviews or focus group discussions with
healthcare providers and patients. Cost evaluation will utilize activity-based costing and
cost-effectiveness analysis.
The study aims to generate evidence on the effectiveness and implementation of an enhanced
model for hepatitis B screening and care linkage within a primary care setting at a public
hospital. The findings are anticipated to be applicable to similar settings in Viet Nam and
other lower-middle-income countries globally.